Past Events


Best Practice in Modelling and Simulation

Together with the Special Interest Group on M&S, EFSPI is organising a Webinar on Best Practice in Modelling and Simulation

Biomarkers and Subgroups

Netherlands | June 2016

Application of Methods for Health Technology Assessment

Joint EFSPI / BBS Meeting | June 2015, Basel

Joint BBS-EFSPI Seminar on Data Sharing in Clinical Development

November 13th 2014 | For Slides follow the link:

Meeting Report

EFSPI/PSI Structured Benefit-Risk 17th September 2013

EFSPI/PSI - Structured Benefit-Risk Assessment

September 2013 | London

Health Technology Assessment - Joint BBS/EFSPI Seminar Programme

On June 4th 2013, the EFSPI and BBS organized a one day meeting on Health Technology Assessment. Over 115 attendees with various backgrounds attended this meeting.

European Statistical Meeting on Subgroup Analysis

Friday 30th November 2012, Brussels - Subgroups analyses are important for a comprehensive assessment of confirmatory trials in marketing authorisation application. Indeed, the CHMP is currently preparing a guideline on this topic. This meeting aim

Joint European Statistical Meeting - EFSPI/BBS/MSB - Modelling and Simulation and applications

Basel, Switzerland, 13th September 2012 Modelling and Simulation is a broad area appealing to many quantitative scientists and increasingly applied in clinical drug development. The meeting will include presentations on the role of M&S in drug devel

Joint European Workshop FMS/EFSPI/DSBS: Benefit-Risk Assessment Methodology Workshop

Malmo, Sweden, 7th June 2012 An increase in the use of quantitative Benefit-Risk Assessment methods has been proposed to aid in the evaluation of new medicinal products by regulatory bodies and reimbursement committees throughout the world. This wor



European Statistical Meeting: Advances in the Treatment of Missing Data

Brussels,18 November 2011 The treatment of missing data continues to be a challenge in the analysis of clinical trials, potentially affecting the integrity and validity of trial results if not handled appropriately. This meeting aims to bring togeth

EFSPI-SFdS-B&S Joint European Statistical Meeting

Paris, 18-19 November 2010 The European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmacy and Health Group of the SFdS (???Soci??t?? Fran??aise de Statistique???, French Society for Statistics) held their joint on

Joint EFSPI-BBS meeting, Basel, 24th June 2010 European Statistical Meeting on Oncology

The meeting was aimed at statisticians who have an interest in Oncology or wish to gain a greater understanding.

Joint EFSPI-MHRA meeting - Statistics at the frontier of drug development

The meeting intended to provide a unique opportunity for discussion amongst industry, regulatory and academic scientists.



European Statistical Meeting on Meta Analysis

This meeting was a joint venture between EFSPI and BBS

European Statistical Meeting on Non-Inferiority

Verona, Italy, November 20th 2008 This meeting was a joint venture between EFSPI, BIAS and SSFA. Non-inferiority trials have been around for many years, but are still controversial. Experts from industry, academia and regulatory bodies have present

Joint PSI-EFSPI Conference

Brussels, May 18th-21st, 2008 | This was a European Conference aimed at Statisticians in the Pharmaceutical Industry. Many opinion leaders from industry, academia and regulatory have spoken. The conference contained many parallel sessions to provide

DIA Workshop on New ICH Guideline on Choice of Control Group in Clinical Trials

The Key Statistical Issues | Brussels November 1999

Presentation on Annual DIA Meeting

Washington DC June 1994

DIA Forum on European Biostatistics Guidelines

London October 1993

Presentation on ISI 49th session in Florence

Florence August 1993